Navigation Links


Zenvia at Biology News

Zenvia at Biology Products
Zenvia at Biology Technology
Zenvia at Medicine News
Zenvia at Medicine Products
Zenvia at Medicine Technology

AVANIR Pharmaceuticals Presents Zenvia Phase III Data in Diabetic Peripheral Neuropathic Pain at International Congress on Neuropathic Pain

ALISO VIEJO, Calif.--(BUSINESS WIRE)--Jun 8, 2007 - AVANIRPharmaceuticals (NASDAQ:AVNR) today announced the presentation ofPhase III data, including efficacy, safety and improvements inpatient-centered outcomes in patients with diabetic peripheralneuropathic (DPN) pain treated with the investigational drugZenvia(TM) (dextromethorphan/quinidine (DM/Q)), an NMDA receptorantagonist and sigma-1...

AVANIR Pharmaceuticals to Present Zenvia Phase III Data in Diabetic Peripheral Neuropathic Pain at Second International Congress on Neuropathic Pain

ALISO VIEJO, Calif.--(BUSINESS WIRE)--May 8, 2007 - AVANIRPharmaceuticals (NASDAQ:AVNR) today announced Phase III data on theefficacy, safety and improvements in patient-centered outcomes inpatients with diabetic peripheral neuropathic (DPN) pain treatedwith the investigational drug Zenvia(TM) (dextromethorphan /quinidine) will be presented in two scientific posters at theSecond Internation...

Avanir Pharmaceuticals Presents IEED Prevalence and Updated Zenvia Long-Term Safety Data at AAN Annual Meeting

ALISO VIEJO, Calif.--(BUSINESS WIRE)--May 1, 2007 - AvanirPharmaceuticals (NASDAQ:AVNR) today announced that data on thelong-term safety of the investigational drug Zenvia(TM)(dextromethorphan / quinidine) and the prevalence of InvoluntaryEmotional Expression Disorder (IEED) were presented today during aposter session at the American Academy of Neurology (AAN) 59thAnnual Meeting in Boston....

Avanir Pharmaceuticals Announces Positive Results of Phase III Study for Zenvia in Diabetic Neuropathic Pain

ALISO VIEJO, Calif.--(BUSINESS WIRE)--Apr 18, 2007 - AvanirPharmaceuticals (NASDAQ:AVNR) today announced positive top-lineresults from the company's Phase III clinical trial evaluating theinvestigational drug Zenvia(TM) (dextromethorphanhydrobromide/quinidine sulfate ("DMQ")), an NMDA antagonist andsigma-1 agonist, in diabetic neuropathic pain. The primary endpoint of the trial was based...
Other Tags
(Date:8/29/2008)...tional Pediatric AIDS Initiative Will Impro...S, WASHINGTON, Aug. 29 /PRNewswire-FirstCall/ -- ...S. government, Baylor College of Medicine, the,gov...U.S. President,s,Emergency Plan for AIDS Relief (P...to improve care and treatment for children with HI...
(Date:8/29/2008)...re/ -- Conseco Insurance Company, a life,and healt...ity of its new,indexed universal life insurance p...side potential with downside protection., Conseco...at offers the,opportunity for long-term cash build...lients can customize their coverage levels with ei...
(Date:8/29/2008)...-USNewswire/ -- The U.S. Department of,Labor propo...e public to,see exactly what goes into agency risk...ter http://edocket.access.gpo.gov/2008/E8-20179.h...test available evidence and,scientific data are us...ndards regulating occupational exposure to toxins ...
(Date:8/29/2008)...-USNewswire/ -- The following is a,statement by Ma...ee Kids:, For the second time in a month, Philip ...ip and promotion of a concert in a developing coun... engaging in cigarette,marketing that appeals to c...has been forced to withdraw from,an August 30 reun...
Breaking Medicine News(10 mins):Health News:Abbott Fund to Build First Pediatric HIV/AIDS Clinic in Tanzania 2Health News:Abbott Fund to Build First Pediatric HIV/AIDS Clinic in Tanzania 3Health News:Abbott Fund to Build First Pediatric HIV/AIDS Clinic in Tanzania 4Health News:ConsecoLifeOptions Launched by Conseco Insurance Company as New Universal Life Product 2Health News:Notice of Proposed Rulemaking on U.S. Department of Labor's Risk Assessment Procedures Published in Federal Register 2Health News:Philip Morris International Forced to Drop Another Concert Sponsorship; Philippines Health Department Applauded for Taking Action 2
(Date:8/28/2008)... NEW YORK (AUGUST 28, 2008) A WCS report...bally threatened primates in a protected area in C...nked douc langurs along with 2,500 yellow-cheeked ...onservation Area, an estimate that represents the ...world., , WCS scientists conducted the surveys ...
(Date:8/28/2008)...rchers at The University of Nottingham have develo... to look at microscopic activity within the body,s..., live as it happens. , The cutting edge laser t...he MRC (Medical Research Council) for a five-year ...y world of activity taking place within single cel...
(Date:8/28/2008)...Journal of Nutrition, Health and Aging publishes ...teraction between nutrition and health in the agin...latest scientific findings on the fundamental impo...pan. The journal is published ten times a year in ..., "The partnership with Springer from 2009 should...
(Date:8/27/2008)...ing in Nature Genetics, and working in conjuncti...tered fund that is dedicated to exploring new aven...y, scientist Robert Hoffmann, has developed the fi... a powerful authorship tracking technology, this n...ponding author. In this way readers can always kno...
Breaking Biology News(10 mins):Unexpected large monkey population discovered 2Life under the laser 2ETH Zurich-administered fund ends scientific anonymity 2Hydration Is Key to Maintaining Health During Hot Summer Months 21651 1Hydration Is Key to Maintaining Health During Hot Summer Months 21651 2STAAR Surgicals LASIK Alternative Expands U S Market Gains 21649 1STAAR Surgicals LASIK Alternative Expands U S Market Gains 21649 2STAAR Surgicals LASIK Alternative Expands U S Market Gains 21649 3STAAR Surgicals LASIK Alternative Expands U S Market Gains 21649 4Social Security Statement Advises Seniors to Consider Private Long Term Care Insurance LTC Agency Reports 3B Medicare Wont Cover It 21647 1Social Security Statement Advises Seniors to Consider Private Long Term Care Insurance LTC Agency Reports 3B Medicare Wont Cover It 21647 2Chindex International Inc Announces Fiscal 2008 Year End and Fourth Quarter Results 5950 1Chindex International Inc Announces Fiscal 2008 Year End and Fourth Quarter Results 5950 2Chindex International Inc Announces Fiscal 2008 Year End and Fourth Quarter Results 5950 3Chindex International Inc Announces Fiscal 2008 Year End and Fourth Quarter Results 5950 4Chindex International Inc Announces Fiscal 2008 Year End and Fourth Quarter Results 5950 5Chindex International Inc Announces Fiscal 2008 Year End and Fourth Quarter Results 5950 6Chindex International Inc Announces Fiscal 2008 Year End and Fourth Quarter Results 5950 7Chindex International Inc Announces Fiscal 2008 Year End and Fourth Quarter Results 5950 8Chindex International Inc Announces Fiscal 2008 Year End and Fourth Quarter Results 5950 9Chindex International Inc Announces Fiscal 2008 Year End and Fourth Quarter Results 5950 10
Other Contentstearstearstearstearsmeniscusmeniscusmenorrhagiaperiodsperiodsperiodsperiodsperiodsperiodsperiodsperiodsperiodsmenstrualmenstrualmenstrualmenstrualmenstrualmentalmentalmentalmentalmentalmentalmentalmentalmesotheliomamesotheliomamesothelioma